TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

CORTROSYN

COSYNTROPIN
Metabolic Approved 1970-04-22
1
Indication
--
Phase 3 Trials
55
Years on Market

Details

Status
Prescription
First Approved
1970-04-22
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

Active Ingredient: COSYNTROPIN

CORTROSYN Approval History

Loading approval history...

What CORTROSYN Treats

1 indications

CORTROSYN is approved for 1 conditions since its original approval in 1970. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Adrenocortical Insufficiency
Source: FDA Label
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CORTROSYN FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

CORTROSYN is indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients. CORTROSYN is an adrenocorticotropin hormone indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.